Fear God (UNDER CONSTRUCTION)

FEAR GOD

Revelation 14: 7 And I saw another angel fly in the midst of heaven, having the everlasting gospel to preach unto them that dwell on the earth, and to every nation, and kindred, and tongue, and people, 7Saying with a loud voice, Fear God, and give glory to him; for the hour of his judgment is come: and worship him that made heaven, and earth, and the sea, and the fountains of waters. 8And there followed another angel, saying, Babylon is fallen, is fallen, that great city, because she made all nations drink of the wine of the wrath of her fornication. 8And there followed another angel, saying, Babylon is fallen, is fallen, that great city, because she made all nations drink of the wine of the wrath of her fornication. 9And the third angel followed them, saying with a loud voice, If any man worship the beast and his image, and receive his mark in his forehead, or in his hand, 10The same shall drink of the wine of the wrath of God, which is poured out without mixture into the cup of his indignation; and he shall be tormented with fire and brimstone in the presence of the holy angels, and in the presence of the Lamb: 11And the smoke of their torment ascendeth up for ever and ever: and they have no rest day nor night, who worship the beast and his image, and whosoever receiveth the mark of his name. 12Here is the patience of the saints: here are they that keep the commandments of God, and the faith of Jesus.

Ecclesiastes 12:13 Let us hear the conclusion of the whole matter: Fear God, and keep his commandments: for this is the whole duty of man.14For God shall bring every work into judgment, with every secret thing, whether it be good, or whether it be evil.

Universality and Cosmology

ANALYZING UNDERLYING IMPETUSES AS REFLECTED IN HISTORY (1840's-present)
Religion Civil Rights Science and Technology Space Forms of government Wars and conflicts
Crimes against humanity Literature Entertainment

Universitarianism reflected in religions, military, and politics. (1800's) III

Friday, October 15, 2010

Lexapro (symbolc misrepresentation)[Lexis-vocabulary, pro-(for, skilled]

Lexapro [Lexis(vocabulary) + Pro]

Escitalopram

From Wikipedia, the free encyclopedia
  (Redirected from Lexapro)
Jump to: navigation, search
Escitalopram
Systematic (IUPAC) name
(S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile
Identifiers
CAS number 128196-01-0
ATC code N06AB10
PubChem CID 146570
DrugBank APRD00683
ChemSpider 129277
UNII 4O4S742ANY
Chemical data
Formula C20H21FN2O 
Mol. mass 324.392 g/mol
(414.43 as oxalate)
SMILES eMolecules & PubChem
Pharmacokinetic data
Bioavailability 80%
Protein binding ~56%
Metabolism Liver, specifically the enzymes CYP3A4 and CYP2C19
Half-life 27–32 hours
Therapeutic considerations
Pregnancy cat. C
Legal status Rx Only (U.S) POM (U.K)
Routes Oral
 Yes(what is this?)  (verify)Y

Lexapro tablets

Cipralex brand escitalopram package and tablet sheet
Escitalopram (trade names Lexapro, Cipralex, Seroplex, Lexamil) is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. It is approved by the U.S. Food and Drug Administration (FDA) for the treatment in adults with major depressive disorder, generalized anxiety disorder, social anxiety disorder , or panic disorder. Escitalopram is the S-stereoisomer (enantiomer) of the earlier Lundbeck drug citalopram, hence the name escitalopram. Escitalopram is noted for its high selectivity of serotonin reuptake inhibition and has side effects typical for the SSRI class.

Contents

[show]

[edit] History

Escitalopram was developed in a close cooperation between Lundbeck and Forest Laboratories. Its development was initiated in the summer of 1997, and the resulting new drug application was submitted to the U.S. FDA in March 2001. The short time (3.5 years) it took to develop escitalopram can be attributed to the previous extensive experience of Lundbeck and Forest with citalopram, which has similar pharmacology.[1]evergreening"[2] (also called "lifecycle management"[3])– the long-term strategy pharmaceutical companies use in order to extend the lifetime of a drug, in this case of the citalopram franchise. Escitalopram is an enantiopure compound of the racemic mixture citalopram, used for the same indication, and for that reason it required less investment and less time to develop. Two years after escitalopram's launch, when the patent on citalopram expired, the escitalopram sales successfully made up for the loss. On May 23, 2006, the FDA approved a generic version of escitalopram by Teva.[4] On July 14 of that year, however, the U.S. District Court of Delaware decided in favor of Lundbeck regarding the patent infringement dispute and ruled the patent on escitalopram valid.[5] The FDA issued the approval of escitalopram for major depression in August 2002 and for generalized anxiety disorder in December 2003. Escitalopram can be considered an example of "
In 2006 Forest Laboratories was granted an 828 day (2 years and 3 months) extension on its US patent for escitalopram.[6] This pushed the patent expiry from December 7, 2009 to March 14, 2012.

By Years

1833 (1) 1836 (1) 1844 (11) 1848 (3) 1850 (2) 1862 (1) 1863 (1) 1866 (1) 1867 (1) 1898 (1) 1932 (2) 1935 (1) 1938 (3) 1939 (1) 1947 (2) 1950 (1) 1958 (1) 1960 (1) 1961 (1) 1962 (1) 1964 (6) 1965 (1) 1966 (2) 1967 (2) 1968 (1) 1969 (1) 1972 (1) 1973 (1) 1976 (1) 1977 (3) 1978 (2) 1979 (15) 1980 (2) 1981 (9) 1982 (3) 1984 (1) 1986 (1) 1989 (6) 1990 (17) 1991 (10) 1992 (4) 1993 (15) 1994 (4) 1997 (2) 1999 (3) 2001 (3) 2002 (4) 2003 (2)

Search This Blog